EDN1 and major depressive disorder: Endothelin-1 (ET1) and ET1 B-type receptors (ETBRs) signaling pathways in the amygdala have been shown to contribute to the attenuation of anxiety and depression [49] raising the possibility that receptor interference, through the presence of autoantibodies, would result in enhanced anxiety and depression.